Literature DB >> 33066945

Current Recommendations for the Management of Stroke Patients in the Middle East in the Era of COVID-19 Pandemic; Statement from the MENA SINO.

Amal M Al Hashmi1, Atilla Ozcan Ozdemir2, Ashfaq Shuaib3, Hosam Al-Jehani4, Ossama Yassin Mansour5, Adel Alhazzani6, Farid Aladhem7, Mehdi Farhoudi8, Seby John9, Maher Saqqur10.   

Abstract

COVID-19 pandemic has led to a change in the way we manage acute medical illnesses. This pandemic had a negative impact on stroke care worldwide. The World Stroke Organization (WSO) has raised concerns due to the lack of available care and compromised acute stroke services globally. The numbers of thrombolysis and thrombectomy therapies are declining. As well as, the rates and door-to treatment times for thrombolysis and thrombectomy therapies are increasing. The stroke units are being reallocated to serve COVID-19 patients, and stroke teams are being redeployed to COVID-19 centers. Covid 19 confirmed cases and deaths are rising day by day. This pandemic clearly threatened and threatening all stroke care achievements regionally. Managing stroke patients during this pandemic is even more challenging at our region. The Middle East and North Africa Stroke and Interventional Neurotherapies Organization (MENA-SINO) is the main stroke organization regionally. MENA-SINO urges the need to developing new strategies and recommendations for stroke care during this pandemic. This will require multiple channels of interventions and create a protective code stroke with fast triaging path. Developing and expanding the tele-stroke programs are urgently required. There is an urgent need for enhancing collaboration and cooperation between stroke expertise regionally and internationally. Integrating such measures will inevitably lead to an improvement and upgrading of the services to a satisfactory level.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Acute Stroke; COVID-19 Pandemic; Challenges; Middle East and North Africa Stroke and Interventional Neurotherapies Organization (MENA SINO); Recommendations; Stroke Care; Stroke Services; World Stroke Organization (WSO)

Mesh:

Year:  2020        PMID: 33066945      PMCID: PMC7375312          DOI: 10.1016/j.jstrokecerebrovasdis.2020.105181

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


In this communication, we present recommendations for the Middle East and North Africa Stroke and Interventional Neurotherapies Organization (MENA-SINO) stroke centers that have been reviewed and approved by stroke regional experts.

Background

Stroke is a common medical emergency and requires urgent evaluation, imaging, and treatment. In patients that present early to the hospital, the patients are evaluated for possible intravenous thrombolysis and mechanical thrombectomy. Patients are subsequently admitted to the Stroke Unit as they recover. Stroke patients are frequently extremely ill in the initial days following the acute event and require constant nursing care. Patients that show slower recovery may be transferred to a rehabilitation ward. The care of stroke patients though their journey in the hospital has become challenging in the presence of current pandemic of Covid 19.1, 2, 3 Many challenges contribute to the suboptimal care due to lack during the pandemic. These include the availably of fewer medical staff due to deployment in other parts of the hospital or illness, conservative approach due to fear of a high risk of infection, deferral of the medical resources into the pandemic-specific hospitals, patient's deferral in coming to the ED. The development of stroke-specific protocols is critical and urgently required so that a regional standardized approach can be offered in the management of stroke patient in the pandemic era. The initiation of tele stroke assessment of patients in the clinic and screening suspected stroke patients in the ED can easily be the first steps. Patients who require in-person evaluation, for example triaging for thrombolysis and/or thrombectomy and transfer to the stroke unit should only be done with protective personal equipment (PPE) when COVID-19 is suspected or the hospital is in a region with higher number of infections. Several stroke assessment proposals have been developed in that regard. For an example, the stroke team in the University of Calgary came with protected code stroke protocol where patient with acute stroke or his relative will be screened for COVID-19 by a set of questioners and based on that protective protocol can be activated. Middle East and North Africa stroke and interventional neurotherapies organization (MENA-SINO) is the main stroke organization in the Middle East, North Africa, Iran, Turkey, and constitutes of the main stroke leaders in the region. The stroke experts from the representative countries developed a consensus statement on the main recommendations for the management of stroke patient in the MENA-SINO region.

The epidemiology of stroke and Covid 19 in the Middle East

The epidemiological curve of COVID -19 virus is steadily increasing globally. The internationally recognized John Hopkins University web site confirmed on July 8, 2020 a total of 11,799,443 COVID-19 cases globally with 543,558 deaths and total of 188 affected countries and regions. The total reported cases in our region have increased to 1,177,618 confirmed cases with total of 29,199 deaths. Our clinical experience and knowledge on how the COVID-19 virus effects the human body and the central nervous system (CNS) is increasing daily. COVID-19 not only affect respiratory and digestive systems as was learned earlier but seems to attack and affect additional body systems and organs. COVID-19 infections have a broad and variable clinical spectrum. The nervous system is not immune against COVID-19 infections. The data relating to CNS involvement is limited and prospective studies are yet to be published. We have learned through limited retrospective case series from China that the virus can attack both central and peripheral nervous systems. Neurological involvement is evident in up to 36% of COVID-19 patients. , Dizziness was the most encountered symptom (16.8%). This was followed by headache (13.1%), and encephalopathy (2.8%). Other symptoms include anosmia (5.1%), dysgeusia (5.6%), and muscle injury (10.1%). The relationship between COVID-19 and stroke incidence remains to be determined. Preliminary studies suggest that there may be an increase in cerebrovascular disease with the infection. This is likely related to a pro-coagulant state seen with COVID-19 infections. In a study of 214 COVID-19 cases from Wuhan, China, stroke occurred in 6 cases (2.8%). Most of the cases were ischemic infarctions except for one hemorrhagic stroke. Although this group of patients had the traditional stroke risk factors, they also suffered from severe pneumonia related to their COVID-19 infection. Aggarwal et al suggests that COVID-19 pandemic has major implications for stroke care. Stroke patients seem to particularly susceptible to developing complications and death when suffering COVID-19 infection. Stroke patients may develop COVID-19 after admission and treatment for stroke or may have asymptomatic SARS-CoV-2 infection. There have been several explanations to link the association of COVID-19 and stroke development; these includes hypercoagulability due to critical illness and cardio embolism from virus-related cardiac injury. The COVID-19 virus may also play a direct role through the injury of the human angiotensin converting enzyme, ACE2, expressed in epithelial cells throughout the body, including in the central nervous system. Other coronaviruses, including SARS-CoV-1 and MERS-Cove have been identified in the brains of patients (case reports) and heavily in the brains of mice that express human ACE2. , Further studies are needed to better understand the relationship between COVID-19 and stroke development. Lately, there case series published in the NEJM that revealed possible relation between COVID 19 and embolic stroke in young.

The current challenges and impact of COVID-19 on the stroke management in the MENA regions

A lack or limited availability of PPE and its appropriate use has resulted in compromised stroke care due to fear of exposure. Due to fear of contracting the disease, a significant decline in TIA and minor stroke evaluation in the hospital. The lack or absence of telestroke service in the region has limited an alternative option for providing assessment, evaluation and management for TIA and minor stroke. Culture barriers as a result of poor understanding of medical diseases and language in the MENA region has led to limitations with screening for COVID 19 or create discomfort among medical staff in dealing with uncertain stroke cases. The redeployment of stroke teams to emergency and ICU departments has led to severe shortage of stroke team personnel and therefore compromising the optimal care needed to be provided to stroke patients. Conversion of stroke units into COVID 19 ICU in some countries leading to compromised care of stroke patients. Absence or decreased rehabilitation session provided by rehabilitation team due lack of PPE or fear of exposure limiting the rehabilitation role in recovery of stroke patients.

We suggest the following recommendations

As the COVID-19 pandemic increases in the MENA-SENO region. We recommend the following changes at different levels of stroke care: I- Prehospital Stage: In case patient must be transferred to the hospital the following measures need to be taken Infection control screening, history of infection or contact with infected person or travel history by paramedic if possible. Using PPE including mask, face shield, gloves, and gown when available as per local hospital protocol, especially when the risk of contact is high or unknown. Prenotification to hospital stroke and in cases of suspected COVID -19. Separate pathways and triaging for stroke patients with or suspected of COVID-19 infection versus where Covid-19 infection is not suspected. It is critical to enhance the public awareness in the MENA region about COIVD 19 disease symptoms and method of prevention and screening through podcast social media and workshops in different languages for all ethnic groups. II- Hospital stage Emergency room Establishing protective code stroke protocol similar to the one developed at the University of Calgary (11) that includes the following measures: Screening for symptoms of COVID 19; travel or contact history, presence of fever, cough, chest pain, dyspnea, headache, myalgias, gastrointestinal symptoms or any others Personal Safety of stroke team; follow (local, CDC and WHO protocols) including guidelines for hand washing, PPE use, COVID-19 testing and evaluation, and self-quarantine as needed. Adherence to acute Stroke Guidelines. Continue treating stroke patients as appropriate with full adherence to guidelines.

CT room

A dedicated CT scan room for COVID-19 patients should be established if multiple CT rooms are available. If there are positive pulmonary symptoms, consider low dose chest CT at the same time as the performance of CT head with CT angiography (CTA) head and neck Avoid multiple visits to the CT room to minimize exposure all necessary imaging must be done same time If within window for thrombolysis adhere to thrombolysis therapy protocol. Dedicate one member of the stroke team to evaluated and provide the therapy. Armed the stroke team with PPE, follow local or international protocols when available and take all the protective measures. Patients eligible for thrombectomy should not be deprived from the procedure.

Angiography suite

Alert Angio suite team about suspect of COVID-19. Minimize the number of personnel at the angiography suite to the minimum required Provide all angiography suite personnel with PPE Alert the anesthesiologist of a COVID-19 or suspect patient. Local policies for intubation and general anesthesia versus conscious sedation differ at different centers. Follow local guidelines Consider conscious sedation as first-line to protect anesthesiologists from exposure, and to protect our patients from unnecessary intubation as well as conserving mechanical ventilator resources. Avoid Converting a patient from conscious sedation to general anesthesia in the middle of the procedure in the angiography suite due to high risk of aerosolization in a positive pressure room. Transfer of the patient from angiography suite to ICU or stroke unit should be done by the same team to avoid and minimize the exposure of other personnel. Proper sterilization procedure of the whole angiography suite must be done once the procedure is over

Stroke unit

Splitting the stroke unit to COVID -19 VS non COVID -19 area if feasible. Provide all stroke team with PPE, enhance, and encourage frequent hand washing and all other protective measures. (follow the local protocol) COVID-19 or suspect case should be followed and monitored by the same personnel to minimize exposure. Adhere to stroke protocol and avoid unnecessary compromise on the care provided. CTA should substitute the carotid doppler unless it is contraindicated to prevent unnecessary exposure of the radiographer due to proximity during the procedure. MRI should only be done with extreme necessity, otherwise CT head should remain the first option, to avoid and minimize time of exposure. Rehabilitation sessions can be provided at the unit when possible to minimize exposure. Provide all the rehabilitation team with PPE to be used for COVID 19 positive patients only and encourage frequent hand washing measures (follow local protocols). Limit the rehabilitation sessions to the same personnel to minimize exposure and prevent others from exposure To minimize exposure, increase duration of rehabilitation and decrease frequency to minimize exposure of rehabilitation personnel Frequent sterilization of monitors and equipment used for COVID -19 cases or suspected cases Enhancing and Developing the Tele Stroke services in most of the countries in the region can help facilitate the stroke consultations services 24 hours. Tele stroke is the solution during this crisis, to provide necessary stroke evaluation and avoid unnecessary inter facilities transfer and reduce exposure of stroke team. It is the ideal tool to provide the following: Acute stroke assessment for thrombolysis Acute stroke assessment for non-thrombolysis case Routine care even when pandemic is over TIA and mild stroke evaluation

Post hospital stage

Follow up Can be facelifted through tele stroke consultation to avoid and minimize the stroke team exposure.

Summary

Stroke is a common neurological disease and presents at a younger age in the MENA-SENO region. It is a medical emergency especially when the patient present early following onset of symptoms. Such patients require urgent assessment and imaging. During the current COVID-19 pandemic it is essential that regional stroke program establish strokeCOVID-19 protocols. Such protocols will be very help in the rapid assessment of the acute stroke patients. It will also ensure the safety of the hospital staff and reduce the risk of infection to the patients. We provide a summary of the limitations that are important in the MENA-SENO region and we also propose recommendations that may be helpful in the care when patients with suspected stroke presents to the hospital in the region.
  9 in total

1.  The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.

Authors:  Linlin Bao; Wei Deng; Baoying Huang; Hong Gao; Jiangning Liu; Lili Ren; Qiang Wei; Pin Yu; Yanfeng Xu; Feifei Qi; Yajin Qu; Fengdi Li; Qi Lv; Wenling Wang; Jing Xue; Shuran Gong; Mingya Liu; Guanpeng Wang; Shunyi Wang; Zhiqi Song; Linna Zhao; Peipei Liu; Li Zhao; Fei Ye; Huijuan Wang; Weimin Zhou; Na Zhu; Wei Zhen; Haisheng Yu; Xiaojuan Zhang; Li Guo; Lan Chen; Conghui Wang; Ying Wang; Xinming Wang; Yan Xiao; Qiangming Sun; Hongqi Liu; Fanli Zhu; Chunxia Ma; Lingmei Yan; Mengli Yang; Jun Han; Wenbo Xu; Wenjie Tan; Xiaozhong Peng; Qi Jin; Guizhen Wu; Chuan Qin
Journal:  Nature       Date:  2020-05-07       Impact factor: 49.962

2.  Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature.

Authors:  Gaurav Aggarwal; Giuseppe Lippi; Brandon Michael Henry
Journal:  Int J Stroke       Date:  2020-04-20       Impact factor: 5.266

3.  Neuroinvasion by human respiratory coronaviruses.

Authors:  N Arbour; R Day; J Newcombe; P J Talbot
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Mechanical Thrombectomy for Acute Ischemic Stroke Amid the COVID-19 Outbreak: Decreased Activity, and Increased Care Delays.

Authors:  Basile Kerleroux; Thibaut Fabacher; Nicolas Bricout; Martin Moïse; Benoit Testud; Sivadji Vingadassalom; Héloïse Ifergan; Kévin Janot; Arturo Consoli; Wagih Ben Hassen; Eimad Shotar; Julien Ognard; Guillaume Charbonnier; Vincent L'Allinec; Alexis Guédon; Federico Bolognini; Gaultier Marnat; Géraud Forestier; Aymeric Rouchaud; Raoul Pop; Nicolas Raynaud; François Zhu; Jonathan Cortese; Vanessa Chalumeau; Jérome Berge; Simon Escalard; Grégoire Boulouis
Journal:  Stroke       Date:  2020-05-20       Impact factor: 7.914

5.  Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.

Authors:  Yanan Li; Man Li; Mengdie Wang; Yifan Zhou; Jiang Chang; Ying Xian; David Wang; Ling Mao; Huijuan Jin; Bo Hu
Journal:  Stroke Vasc Neurol       Date:  2020-07-02

6.  Acute Stroke Care Is at Risk in the Era of COVID-19: Experience at a Comprehensive Stroke Center in Barcelona.

Authors:  Salvatore Rudilosso; Carlos Laredo; Víctor Vera; Martha Vargas; Arturo Renú; Laura Llull; Víctor Obach; Sergio Amaro; Xabier Urra; Ferrán Torres; Francesc Xavier Jiménez-Fàbrega; Ángel Chamorro
Journal:  Stroke       Date:  2020-05-22       Impact factor: 7.914

7.  SARS-CoV-2 and Stroke in a New York Healthcare System.

Authors:  Shadi Yaghi; Koto Ishida; Jose Torres; Brian Mac Grory; Eytan Raz; Kelley Humbert; Nils Henninger; Tushar Trivedi; Kaitlyn Lillemoe; Shazia Alam; Matthew Sanger; Sun Kim; Erica Scher; Seena Dehkharghani; Michael Wachs; Omar Tanweer; Frank Volpicelli; Brian Bosworth; Aaron Lord; Jennifer Frontera
Journal:  Stroke       Date:  2020-05-20       Impact factor: 7.914

8.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).

Authors:  Tao Guo; Yongzhen Fan; Ming Chen; Xiaoyan Wu; Lin Zhang; Tao He; Hairong Wang; Jing Wan; Xinghuan Wang; Zhibing Lu
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

9.  Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic.

Authors:  Houman Khosravani; Phavalan Rajendram; Lowyl Notario; Martin G Chapman; Bijoy K Menon
Journal:  Stroke       Date:  2020-04-01       Impact factor: 7.914

  9 in total
  4 in total

Review 1.  Neurological Complications of COVID-19: Underlying Mechanisms and Management.

Authors:  Ghaydaa A Shehata; Kevin C Lord; Michaela C Grudzinski; Mohamed Elsayed; Ramy Abdelnaby; Hatem A Elshabrawy
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

2.  Lessons learned in stroke care during COVID-19 pandemic and preparing for future pandemics in the MENA+ region: A consensus statement from the MENA+-SINO.

Authors:  Amal Al Hashmi; Stephan von Bandemer; Ashfaq Shuaib; Ossama Yassin Mansour; Mohammed Wassy; Atilla Ozcan Ozdemir; Mehdi Farhoudi; Hosam Al Jehani; Adnan Khan; Seby John; Maher Saqqur
Journal:  J Neurol Sci       Date:  2021-11-27       Impact factor: 3.181

3.  It's not always Occam's razor: The pivotal role of telemedicine in stroke patients amidst the COVID-19 pandemic.

Authors:  Talal Almas; Maryam Ehtesham; Uzair Malik; Vikneswaran Raj Nagarajan; Mahnoor Sukaina; Norah Alshareef; Ahlam Alzahrani; Suliman Abuhaimed; Yohan Porus Irani; Enaam Alzadjali; Eissa Sultan Alwheibi; Mhmod Kadom; Saif Khalid; Muhammad Shehryar; Khalid Muhammad Al Shumrani
Journal:  Ann Med Surg (Lond)       Date:  2022-03-28

4.  Burden of stroke in North Africa and Middle East, 1990 to 2019: a systematic analysis for the global burden of disease study 2019.

Authors:  Ataollah Shahbandi; Parnian Shobeiri; Sina Azadnajafabad; Sahar Saeedi Moghaddam; Yeganeh Sharifnejad Tehrani; Narges Ebrahimi; Nazila Rezaei; Mohammad-Mahdi Rashidi; Seyyed-Hadi Ghamari; Mohsen Abbasi-Kangevari; Sogol Koolaji; Rosa Haghshenas; Negar Rezaei; Bagher Larijani; Farshad Farzadfar
Journal:  BMC Neurol       Date:  2022-07-27       Impact factor: 2.903

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.